Bowel Preparation Solutions Clinical Trial
Official title:
Randomized Comparison of the Impact of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Versus Polyethylene Glycol Bowel Preparation on Inpatient Colonoscopy Quality Parameters
Verified date | February 2021 |
Source | The Cleveland Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a prospective randomized study which will be done at main campus Cleveland Clinic. The investigators will be comparing the colon cleansing by the Boston Bowel Preparation Scale in participants undergoing colonoscopy as an inpatient at our hospital. Participants will be randomized to the the standard of care (4 Liter polyethylene glycol based preparation) or a low volume bowel preparation (sodium picosulfate, a stimulant laxative, magnesium oxide and anhydrous citric acid (SP/MC)). Both agents will either be administered as full dose the evening before or as split-dose on the evening before and on the day of the procedure.
Status | Terminated |
Enrollment | 14 |
Est. completion date | March 26, 2019 |
Est. primary completion date | March 26, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients who need a colonoscopy while in the hospital (Cleveland Clinic main campus) will be eligible to participate. Exclusion Criteria: - Creatinine clearance less than 30 ml/min - History of heart failure with current shortness of breath at rest causing limited physical activity, arrhythmia, unstable angina or acute myocardial infarction - Small bowel obstruction, ileus or bowel perforation - Dementia or cognitive dysfunction to an extent that they cannot perform the study related documentation or consent to participate in the study. - Gastroparesis - Toxic megacolon or undergoing colonoscopy for decompression - Taking oral tetracyclines, fluoroquinolones, antibiotics, iron, digoxin, chlorpromazine and penicillamine within 2 hours before or 6 hours after administration of Clenpiq or stimulant laxatives within 24 hours - History of prior colorectal surgery - Allergy to any of the ingredients in Clenpiq or golytely - if the procedure is planned in the intensive care unit (ICU) |
Country | Name | City | State |
---|---|---|---|
United States | Cleveland Clinic | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
The Cleveland Clinic | Ferring Pharmaceuticals |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of Participants With Satisfactory Bowel Cleansing | Bowel cleansing efficacy will be measured using the Boston Bowel Prep Scale (BBPS). The BBPS divides the colon into 3 segments (right, transverse, left); each is scored from 0-3 (0=colonic mucosa not seen due to solid stool that cannot be cleared, 1=only a portion of the mucosa of the colon segment is seen due to staining, residual stool and/or opaque liquid, 2=minor amount of residual staining, small fragments of stool and/or opaque liquid but mucosa of colon segment is seen well, and 3=entire mucosa is seen well with no residual staining, small fragments of stool or opaque liquid). A total BBPS score of 6 or greater AND 2 or greater in all segments will be defined as satisfactory bowel prep. BBPS score of less than 6 or less than 2 in any segment of the colon will be taken as unsatisfactory bowel cleansing in the final analysis. | 1 day | |
Secondary | Proportion of Participants Requiring a Repeat Colonoscopy | Participants requiring a repeat procedure due to unsatisfactory bowel prep | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01627171 -
Colonoscopy Preparation Optimization for INpatients- COIN Study
|
Phase 4 | |
Completed |
NCT03329339 -
The Effect of 1L Polyethylene Glycol Plus Ascorbic Acid With Prepackaged Low-Residue Diet for Bowel Preparation
|
N/A | |
Not yet recruiting |
NCT04446195 -
The Effect of Individualized Intervention on the Quality of Bowel Preparation
|
N/A | |
Completed |
NCT03925506 -
Predictive Factors of Inadequate Bowel Preparation in Inpatients
|
||
Recruiting |
NCT04474002 -
Efficacy, Tolerance and Safety of Split Dose Bowel Preparation for Colonoscopy: 4L Polyethylene Glycol (PEG) Versus 1L Polyethylene Glycol Plus Sodium Picosulfate-magnesium Citrate (SPMC)
|
Phase 4 |